Company Filing History:
Years Active: 2014-2023
Title: Innovations by Deepa Chitre in COVID-19 Treatment
Introduction
Deepa Chitre is an accomplished inventor based in Los Gatos, California. She has made significant contributions to the field of medicine, particularly in the treatment of COVID-19. With two patents to her name, her work focuses on innovative methods and compounds aimed at combating the effects of this global pandemic.
Latest Patents
Deepa Chitre's latest patents include groundbreaking methods and compounds for treating the effects of COVID-19 disease. These patents detail methods for preventing and arresting COVID-19 morbidity and mortality through the inhibition of Interleukin-6, TNF-alpha, and other cytokines. Her research highlights the hyperactivation of the immune system in patients with COVID-19 complicated by ARDS, which leads to a significant surge of harmful cytokines. The example oral formulations, dubbed BV-4051 and Artovid-20, provide both prophylaxis and treatment for conditions caused by COVID-19. These formulations contain plant extracts that boost the human immune system and target the detrimental effects of the SARS-CoV-2 virus in its various strains. Additionally, she has developed a method for extracting pharmacologically active ingredients from plants, resulting in fractions that are therapeutically more effective and less toxic than those obtained by conventional methods.
Career Highlights
Deepa Chitre is currently associated with Bioved Pharmaceuticals, Inc., where she continues to innovate in the field of pharmaceutical research. Her work is characterized by a commitment to improving health outcomes through scientific advancements.
Collaborations
Some of her notable coworkers include Debendranath Dey and Satej R Nadkarni, who contribute to her research efforts and collaborative projects.
Conclusion
Deepa Chitre's innovative work in developing treatments for COVID-19 showcases her dedication to advancing medical science. Her patents reflect a significant step forward in addressing the challenges posed by the pandemic.